Amendment: SEC Form SCHEDULE 13D/A filed by Acuren Corporation

Item 3 is supplemented as follows: The Reporting Persons did not expend any funds in connection with the execution of the Voting Agreement (as defined below). The Voting Agreement is described in more detail in Item 4 below.

Item 4 of the Statement is supplemented as follows: Merger Agreement On May 14, 2025, the Issuer entered into an Agreement and Plan of Merger by and among the Issuer, NV5 Global, Inc., a Delaware corporation ("NV5"), Ryder Merger Sub I, Inc., a Delaware corporation ("Merger Sub I"), and Ryder Merger Sub II, Inc., a Delaware Corporation ("Merger Sub II") (the "Merger Agreement") pursuant to which the Issuer will acquire all of the issued and outstanding shares of common stock of NV5 (other than shares held by any of the Issuer, Merger Sub I, Merger Sub II, NV5 or their affiliates and shares of NV5 subject to appraisal demands in accordance with applicable Delaware law) for $10.00 in cash, without interest, and a number of shares of Common Stock equal to the Exchange Ratio (as defined in the Merger Agreement) for each share of common stock of NV5. Voting Agreement In connection with the execution of the Merger Agreement, on May 14, 2025, Mariposa entered into a voting support agreement (the "Voting Agreement") with NV5, under which Mariposa agreed, among other things, to vote, or cause to be voted, all of the shares of the Issuer's Common Stock beneficially owned by it in favor of the adoption of the Merger Agreement and/or against the approval or adoption of any alternative acquisition proposal by the Issuer. The Voting Agreement also contains restrictions on the transfer of shares of the Issuer's Common Stock held by Mariposa. In addition, the Voting Agreement will automatically terminate, without notice or action by any parties, upon the earlier of the (i) receipt of approval of the Acuren Stock Issuance (as defined in the Merger Agreement), (ii) termination of the Merger Agreement in accordance with its terms, and (iii) as mutually agreed by NV5 and Mariposa. The foregoing description of the Voting Agreement is qualified by reference to the Voting Agreement, a copy of which is attached hereto as Exhibit E and is incorporated by reference into this Item 4.

Item 5 is supplemented as follows: Except for the Voting Agreement described in Item 4 above, no transactions in the Common Stock were effected.

Item 6 is hereby amended and supplemented by the information set forth above in Item 4 which is incorporated herein by reference.

Exhibit A -- Joint Filing Agreement among the Reporting Persons, dated February 14, 2025. Exhibit B -- Placing Agreement, dated May 17, 2023, by and between the Issuer, certain of its directors and founders, Mariposa, Jefferies International Limited, Jefferies GmbH and UBS AG London Branch (incorporated by reference to Exhibit 10.8 to the Issuer's Registration Statement on Form S-4, as amended (File No. 333-282976)). Exhibit C -- Founder Insider Letter, dated May 17, 2023, by and between the Issuer, its founders and Mariposa (incorporated by reference to Exhibit 10.10 to the Issuer's Registration Statement on Form S-4, as amended (File No. 333-282976)). Exhibit D -- Certificate of Incorporation of the Issuer (incorporated by reference to Exhibit 3.1 to the Issuer's Post-Effective Amendment No. 1 to Registration Statement on Form S-4, as amended (File No. 333-282976), filed with the SEC on December 16, 2024, which contains the terms of the Series A Preferred Stock). Exhibit E -- Voting Support Agreement, by and among NV5 Global, Inc. and Mariposa Acquisition IX, LLC, dated May 14, 2025.